Mamaghani, S., Patel, S., & Hedley, D. W. (2009). Glycogen synthase kinase-3 inhibition disrupts nuclear factor-kappaB activity in pancreatic cancer, but fails to sensitize to gemcitabine chemotherapy. BioMed Central.
Citação norma ChicagoMamaghani, Shadi, Satish Patel, and David W. Hedley. Glycogen Synthase Kinase-3 Inhibition Disrupts Nuclear Factor-kappaB Activity in Pancreatic Cancer, but Fails to Sensitize to Gemcitabine Chemotherapy. BioMed Central, 2009.
Deismireacht MLAMamaghani, Shadi, Satish Patel, and David W. Hedley. Glycogen Synthase Kinase-3 Inhibition Disrupts Nuclear Factor-kappaB Activity in Pancreatic Cancer, but Fails to Sensitize to Gemcitabine Chemotherapy. BioMed Central, 2009.
Rabhadh: D'fhéadfadh nach mbeadh na deismireachtaí seo 100% cruinn i gcónaí.